Allianz SE v (ALV) Stock Analysis
Allianz SE is one of Europe's largest diversified financial services companies, operating across property-casualty insurance, life/health insurance, and global asset management. Investors research ALV for its exposure to insurance underwriting, investment management fees, and dividend yield in a mature, regulated industry.
Get a full AI research report on ALV
6-step deep analysis in ~90 seconds. Quick research is free — no signup.
What does Allianz SE v do?
Allianz generates revenue through three main channels: underwriting insurance premiums in property-casualty and life/health segments, earning investment returns on its large asset base, and collecting management fees from its asset management division serving institutional and retail clients. The company operates in over 70 countries, with a diversified customer base spanning individuals, small businesses, and large corporations. Its business model relies on disciplined underwriting, investment performance, and operational efficiency to convert premiums into profit.
Bull case
- ✓Trading at a forward P/E of 13.1x, below its trailing P/E of 14.4x, suggesting the market may be pricing in earnings growth or near-term headwinds.
- ✓Return on equity of 19.6% indicates efficient capital deployment and strong profitability relative to shareholder capital.
- ✓Dividend yield of 3.87% with a payout ratio of 56% suggests sustainable income generation with room for capital retention or reinvestment.
- ✓Diversified revenue streams across insurance underwriting, investment management, and banking reduce dependence on any single business line.
- ✓Strong current ratio of 1.51x and quick ratio of 1.07x indicate solid short-term liquidity to meet obligations and fund operations.
Bear case
- ✗Debt-to-equity ratio of 50.6% is elevated, reflecting significant leverage that could constrain financial flexibility in a downturn or rising rate environment.
- ✗Net profit margin of 9.88% is modest for a financial services company, suggesting thin operating leverage or competitive pressure in underwriting.
- ✗PEG ratio of 3.3 implies the stock may be trading at a premium relative to expected earnings growth, depending on growth assumptions.
- ✗Return on assets of 1.23% is low, indicating the company generates limited profit from its large asset base relative to peers.
- ✗Exposure to interest rate risk, equity market volatility, and insurance underwriting losses could pressure earnings in adverse market conditions.
ALV valuation & financial health
Allianz trades at a forward P/E of 13.1x and trailing P/E of 14.4x, positioning it in the mid-range for diversified insurers. The price-to-book ratio of 2.54x reflects a modest premium to tangible equity value. Profitability metrics are mixed: a 19.6% ROE is healthy, but a 1.23% ROA and 9.88% net margin suggest the company generates modest returns on its large asset base. The 50.6% debt-to-equity ratio is substantial and warrants monitoring, particularly if interest rates remain elevated or underwriting conditions deteriorate. Liquidity appears adequate with a 1.51x current ratio, though the quick ratio of 1.07x indicates reliance on inventory conversion. The 3.87% dividend yield with a 56% payout ratio suggests a sustainable income stream with capital retention capacity.
The bottom line
Allianz presents a balanced profile for investors evaluating a mature, diversified financial services company. The forward P/E discount to trailing earnings and strong ROE are offset by elevated leverage, modest asset returns, and exposure to insurance and market volatility. Key factors to weigh include the sustainability of underwriting profitability, the company's ability to grow asset management fees in a competitive environment, and how rising interest rates or recession scenarios might impact both insurance claims and investment portfolios. Monitoring quarterly earnings, combined ratio trends, and management guidance on capital allocation will be important for assessing whether current valuations reflect fair value or embedded risks.
Frequently asked questions
What does Allianz SE do?
Allianz is a diversified financial services company offering property-casualty insurance, life/health insurance, asset management, and banking services to customers in over 70 countries. It generates revenue from insurance premiums, investment returns, and management fees.
Is ALV overvalued or undervalued?
The forward P/E of 13.1x is below the trailing P/E of 14.4x, suggesting the market may be pricing in near-term earnings pressure or growth. The PEG ratio of 3.3 indicates a potential premium relative to growth expectations, though valuation depends on your earnings forecast and required return.
What is Allianz's dividend yield?
Allianz offers a dividend yield of 3.87% with a payout ratio of 56%, indicating a sustainable income stream backed by retained earnings capacity. Dividend sustainability depends on underwriting profitability and investment returns.
How much debt does Allianz carry?
Allianz has a debt-to-equity ratio of 50.6%, which is elevated for the insurance sector. This leverage is typical for large insurers but increases financial risk in adverse scenarios such as underwriting losses or market downturns.
What are the main risks for ALV investors?
Key risks include insurance underwriting losses, exposure to equity and bond market volatility, interest rate sensitivity, elevated leverage, and competitive pressure in asset management. Regulatory changes and economic downturns could also pressure earnings.
How profitable is Allianz?
Allianz's ROE of 19.6% is strong, but its ROA of 1.23% and net margin of 9.88% are modest, indicating the company generates limited profit from its large asset base relative to some peers. Profitability varies with underwriting cycles and market conditions.
Research ALV with AI in seconds
Company profile, financials, events, competition, risks and synthesis — automated.
Start free — no signupFor informational purposes only — not investment advice. Analysis is AI-generated from public data and may contain errors. Always do your own research.